ORPEA: emeis 2024 Annual General Meeting, Summary of Voting Results
26 June 2024 - 2:55AM
Business Wire
Regulatory News:
Orpea (Paris:ORP):
Guillaume Pepy, Chairman of the Board of Directors: "With a
renewed shareholder base, a restructured balance sheet and a new
identity, we have opened a new page. Today, with the Board of
Directors and the Executive Management team, we are particularly
proud to announce that our Annual General Meeting has enabled us to
introduce the Company's mission statement (raison d'être) «
Together, let’s stand as a strength for the vulnerable among us”
into its Articles of Association. The Group now has everything it
takes to ensure that together, united, our employees, experts and
professionals in care and support for our patients, residents,
their families and loved ones, and players in civil society, can
meet the major challenges facing our society, mental health and the
elderly".
Laurent Guillot, Chief Executive Officer: “At the same time as
our financial restructuring, we laid the human and medical
foundations for the Group, and embarked on an in-depth overhaul.
emeis continues its transformation by strengthening the operational
management and performance of its facilities. Our new identity,
emeis, and our mission statement (raison d'être) are vectors of
performance. They are the expression of the support offered to our
patients, residents, beneficiaries and their families, and require
us to excel and innovate in the quality of care and support
provided every day in our facilities. The proposed transition to a
mission-driven company in 2025 will mark a new stage in our
transformation, a new challenge that together with the Board of
Directors and the determination of all the Group's teams, which I
would like to salute, we are ready to take up. With all the
humility that our businesses inspire, we remain more determined
than ever. Determined to make emeis a resolutely human business
model".
Summary of voting results for other resolutions
During the General Meeting, the required majority of Company
shareholders approved the resolutions relating to:
- the approval of the 2023 financial statements, the
appropriation of profit and the approval of the Auditors’ report on
regulated agreements; - the reappointment of Mireille Faugère,
independent director; - the remuneration and benefits of corporate
officer for the 2023 financial year; - the remuneration policy for
corporate officer for the 2024 financial year; - the renewal or
grant of financial delegations and authorizations to the Board of
Directors; - the granting of delegations to the Board of Directors
to issue the Groupement share warrants and the SteerCo share
warrants (the Board of Directors will implement this delegation in
order to issue the Groupement share warrants and the SteerCo share
warrants over the next few days)1; - amendments to the Company’s
articles of association, in particular to incorporate the Group’s
new identity and mission statement (raison d’être); - the power for
formalities.
The detailed results of the votes are available on the Company’s
website at the following address:
www.emeis-group.com/en/shareholders-investors/shareholders/shareholder-meeting
Finally, Ms Noria Charef was appointed as director representing
employees by the Company’s Central Social and Economic Committee
during its meeting on 11 June 2024, with effect from the close of
the General Meeting.
About emeis
With nearly 78,000 experts and professionals in healthcare,
care, and supporting the most vulnerable among us, emeis operates
in around twenty countries with five core activities: psychiatric
clinics, medical care and rehabilitation clinics, nursing homes,
home care services, and assisted-living facilities.
Every year, emeis welcomes around 283,000 residents, patients,
and other beneficiaries. emeis is committed and taking action to
rise to a major challenge facing our society, i.e, the increase in
the number of people placed in a vulnerable position as a result of
accidents, old age, or cases of mental illness.
emeis is 50.2% owned by Caisse des Dépôts, CNP Assurances, MAIF,
and MACSF Epargne Retraite. It is listed on the Euronext Paris
stock exchange (ISIN: FR001400NLM4) and is a member of the SBF 120
and CAC Mid 60 indices.
Website: www.emeis.com
___________________
1 It should be noted that the shares of the beneficiaries of the
issuance of share warrants without pre-emption rights for
shareholders under 16th to 20th resolutions were excluded from the
vote on the corresponding resolutions pursuant to applicable
regulations.
It is planned to issue 1,170,888 share warrants to the
Groupement (522,795 to Caisse des Dépôts et Consignations, 345,650
to Mutuelle Assurance des Instituteurs de France, 129,619 to CNP
Assurances and 172,824 to MACSF Epargne Retraite) and 1,162,279
share warrants to the SteerCo, giving a total of 2,333,167 share
warrants. Each share warrant will entitle its holder to subscribe,
for a period of six months from the date of settlement/delivery, to
one new ordinary share with a par value of €0.01 each, at a price
of €0.01 per share, with no issue premium. Once issued, they would
entitle their holders to subscribe for shares representing around
1.4% of the Company's capital on a fully diluted basis.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240625405368/en/
Press Contacts Isabelle HERRIER NAUFLE Medias
& e-reputation Director +33 7 70 29 53 74
isabelle.herrier@emeis.com
IMAGE 7 Charlotte LE BARBIER // Laurence HEILBRONN
+33 6 78 37 27 60 // +33 6 89 87 61 37 clebarbier@image7.fr //
lheilbronn@image7.fr
Investor Relations Benoit LESIEUR Investor
Relations Director benoit.lesieur@emeis.com Toll-free number for
shareholders (from France Only) 0 805 480 480
NEWCAP Dusan ORESANSKY +33 1 44 71 94 94
emeis@newcap.com
Orpea (EU:ORP)
Historical Stock Chart
From May 2024 to Jun 2024
Orpea (EU:ORP)
Historical Stock Chart
From Jun 2023 to Jun 2024